[177Lu] Lu-XT033 Injection

· Sinotau Pharmaceutical Group

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [177Lu] Lu-XT033 Injection, covering 2024-05-03 to 2024-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]